Literature DB >> 5818230

Investigation of endocrine exophthalmos.

A N Bowden, F C Ross.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5818230      PMCID: PMC2279022     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN: 0035-9157


× No keyword cloud information.
  7 in total

1.  Clinical and metabolic studies in thyroid disease.

Authors:  E J WAYNE
Journal:  Br Med J       Date:  1960-01-02

2.  Thyroid auto-immunity.

Authors:  I M ROITT; D DONIACH
Journal:  Br Med Bull       Date:  1960-05       Impact factor: 4.291

3.  The urinary excretion of radioiodine as a clinical test of thyroid function.

Authors:  R FRASER; Q J G HOBSON; D G ARNOTT; E W EMERY
Journal:  Q J Med       Date:  1953-01

4.  Extracts from the Presidential Address to the International Society of Clinical Pathology meeting in Rome.

Authors: 
Journal:  J Clin Pathol       Date:  1967-01       Impact factor: 3.411

5.  Adrenals and reproductive organs of female mice kept singly, grouped, or grouped with a vasectomized male.

Authors:  J K MODY; J J CHRISTIAN
Journal:  J Endocrinol       Date:  1962-03       Impact factor: 4.286

6.  The triiodothyronine suppression test.

Authors:  G Burke
Journal:  Am J Med       Date:  1967-04       Impact factor: 4.965

7.  Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

Authors:  L M Lipman; D E Green; N J Snyder; J C Nelson; D H Solomon
Journal:  Am J Med       Date:  1967-10       Impact factor: 4.965

  7 in total
  4 in total

Review 1.  Endocrine exophthalmos.

Authors:  C W Havard
Journal:  Br Med J       Date:  1972-02-05

2.  Dysthyroid eye disease. A trial of guanethidine eye drops.

Authors:  A N Bowden; F C Rose
Journal:  Br J Ophthalmol       Date:  1969-04       Impact factor: 4.638

3.  Endocrine exophthalmos.

Authors: 
Journal:  Br Med J       Date:  1972-07-08

4.  Neuro-ophthalmology.

Authors:  F C Rose
Journal:  J R Coll Physicians Lond       Date:  1974-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.